Synlett, Inhaltsverzeichnis Synlett 2015; 26(06): 737-740DOI: 10.1055/s-0034-1379981 letter © Georg Thieme Verlag Stuttgart · New York Novel SF5-Anilines and SF5-Aryl Ethers from SF5-Substituted Potassium Aryl Trifluoroborates Adrien Joliton Laboratorium für Organische Chemie, ETH Zürich, 8093 Zürich, Switzerland eMail: carreira@org.chem.ethz.ch , Erick M. Carreira* Laboratorium für Organische Chemie, ETH Zürich, 8093 Zürich, Switzerland eMail: carreira@org.chem.ethz.ch › Institutsangaben Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Abstract The copper-catalyzed coupling of SF5-substituted potassium aryl trifluoroborates with amines and alcohols is reported. This method provides a simple access to novel 3-pentafluorosulfanyl-substituted anilines and aryl ethers, which are potential important building blocks for drug discovery and agrochemicals. Key words Key wordspentafluorosulfanyl - copper - arenes - ethers - anilines Volltext Referenzen References and Notes 1a Ji Y, Brueckl T, Baxter RD, Fujiwara Y, Seiple IB, Su S, Blackmond PS, Baran PS. Proc. Natl. Acad. Sci U.S.A. 2011; 108: 14411 1b Fujiwara Y, Dixon JA, Rodriguez RA, Baxter RD, Dixon DD, Collins MR, Blackmond DG, Baran PS. J. Am. Chem. Soc. 2012; 134: 1494 1c Fujiwara Y, Dixon JA, O’Hara F, Funder ED, Dixon DD, Rodriguez RD, Baxter RD, Herle B, Sach N, Collins MR, Ishihara Y, Baran PS. Nature (London, U.K.) 2012; 492: 95 For a recent review about metal-mediated radical perfluoroalkylations, see: 1d Barata-Vallejo S, Postigo A. Coord. Chem. Rev. 2013; 257: 3051 2a Crowley PJ, Mitchell G, Salmon R, Worthington PA. Chimia 2004; 58: 138 2b Stump B, Eberle C, Schweizer WB, Kaiser M, Brun R, Krauth-Siegel RL, Lentz D, Diederich F. ChemBioChem 2009; 10: 79 2c Kirsch P, Bremer M, Heckmeier M, Tarumi K. Angew. Chem. Int. Ed. 1999; 38: 1989 2d Sitzmann ME, Gilligan WH, Ornellas DL, Thrasher JS. J. Energ. Mat. 1990; 10: 352 Reviews about the chemistry of SF5: 3a Altomonte S, Zanda M. J. Fluorine Chem. 2012; 143: 57 3b Savoie PR, Welch JT. Chem. Rev. 2014; in press; dx.doi.org/10.1021/cr500336u 4a Beier P, Pastýříková T, Vida N, Iakobson G. Org. Lett. 2011; 13: 1466 4b Beier P, Pastyrikova T, Iakobson G. J. Org. Chem. 2011; 76: 4781 4c Beier P, Pastyrikova T. Tetrahedron Lett. 2011; 52: 4392 4d Pastyrikova T, Iakobson G, Vida N, Pohl R, Beier P. Eur. J. Org. Chem. 2012; 2123 4e Vida N, Beier P. J. Fluorine Chem. 2012; 143: 130 4f Beier P, Pastyrikova T. Beilstein J. Org. Chem. 2013; 9: 411 5 Frischmuth A, Unsinn A, Groll K, Stadtmuller H, Knochel P. Chem. Eur. J. 2012; 18: 10234 6 Wang C, Yu Y.-B, Fan S, Zhang X. Org. Lett. 2013; 15: 5004 7a Sheppard WA. J. Am. Chem. Soc. 1960; 82: 4751 7b Sheppard WA. J. Am. Chem. Soc. 1962; 84: 3064 8 Umemoto T, Garrick LM, Saito N. Beilstein J. Org. Chem. 2012; 8: 461 9a Sheppard WA. J. Am. Chem. Soc. 1962; 84: 3072 9b Hansch C, Muir RM, Fujita T, Maloney PP, Geiger F, Streich M. J. Am. Chem. Soc. 1963; 85: 2817 9c Bowdem RD, Comina PJ, Greenhall MP, Kariuki BM, Loveday A, Philp D. Tetrahedron 2000; 56: 3399 10a Ishiyama T, Takagi J, Ishida K, Miyaura N, Anastasi NR, Hartwig JF. J. Am. Chem. Soc. 2002; 124: 390 10b Ishiyama T, Takagi J, Hartwig JF, Miyaura N. Angew. Chem. Int. Ed. 2002; 41: 3056 10c Boller TM, Murphy JM, Hapke M, Ishiyama T, Miyaura N, Hartwig JF. J. Am. Chem. Soc. 2005; 127: 14263 10d Murphy JM, Tzchucke CC, Hartwig JF. Org. Lett. 2007; 9: 757 11 Joliton A, Carreira EM. Org. Lett. 2013; 15: 5147 12a Chan DM. T, Monaco KL, Wang R.-P, Winters MP. Tetrahedron Lett. 1998; 39: 2933 12b Evans DA, Katz JL, West TR. Tetrahedron Lett. 1998; 39: 2937 12c Lam PY. S, Clark CG. Saubern S, Adams J, Winters MP, Chan DM. T, Combs A. Tetrahedron Lett. 1998; 39: 2941 13 For a recent review, see: Qiao JX, Lam PY. S. Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials. Hall DG. Wiley-VCH; Weinheim: 2011. 2nd ed. Vol. 1 and 2: 315-361 14 Quach TD, Batay RA. Org. Lett. 2003; 5: 1381 15 Quach TD, Batay RA. Org. Lett. 2003; 5: 43 16 General Procedure for the Preparation of SF5-Anilines A suspension of 1a (118.0 mg, 0.347 mmol, 2.0 equiv), Cu(OAc)2·H2O (3.5 mg, 0.017 mmol, 0.1 equiv), Et3N (24 μL, 0.174 mmol, 1.0 equiv) and powdered 4 Å MS (230 mg) in 1.7 mL DCE was stirred for 5 min at r.t. Then 4-bromoaniline (31.1 mg, 96%, 0.174 mmol) was added, a condenser was set up, and the reaction mixture was stirred at 85 °C under an atmosphere of oxygen (balloon) for 16 h. The reaction mixture was cooled down to r.t., filtered through a pad of Celite, and concentrated in vacuo. Purification was made by column chromatography (hexane–toluene, 8:2 to 7:3) to afford the aniline 3a (50.1 mg, 0.124 mmol, 71%). N-(4-Bromophenyl)-3-methoxy-5-(pentafluorosulfanyl)aniline (3a) Rf = 0.25 (hexanes–EtOAc, 9:1). 1H NMR (300 MHz, CDCl3): δ = 7.47–7.35 (m, 2 H), 7.02–6.93 (m, 3 H), 6.83 (t, J = 2.0 Hz, 1 H), 6.67 (t, J = 2.1 Hz, 1 H), 5.79 (s, 1 H), 3.80 (s, 3 H). 13C NMR (101 MHz, CDCl3): δ = 160.4, 155.7 (p, 2 J CF = 16.8 Hz), 144.4, 140.8, 132.7, 121.0, 115.0, 107.7 (p, 3 J CF = 4.8 Hz), 105.4, 104.6 (p, 3 J CF = 4.6 Hz), 55.9. 19F NMR (282 MHz, CDCl3): δ = 84.4 (app m), 62.4 (d, 2 J FF = 148.4 Hz). IR (neat): 3406, 2940, 2841, 1608, 1586, 1487, 1256, 1197, 1114, 896, 832, 768, 660, 595 cm–1. HRMS (EI): m/z calcd for [C13H11BrF5NOS]+: 402.9660; found: 402.9663. 17 General Procedure for the Preparation of SF5-Aryl Ethers A suspension of 1a (126.0 mg, 0.372 mmol, 2.0 equiv), Cu(OAc)2·H2O (37.0 mg, 0.186 mmol, 1.0 equiv), DMAP (4.5 mg, 0.037 mmol, 0.2 equiv), and powdered 4 Å MS (200 mg) in 1.8 mL DCE was stirred for 5 min to r.t. Then ethyl 4-hydroxybenzoate (31.2 mg, 99%, 0.186 mmol) was added, a condenser was set up, and the reaction mixture was stirred at 60 °C under an atmosphere of oxygen (balloon) for 24 h. The reaction mixture was cooled down at r.t., filtered through a pad of Celite, and concentrated under vacuo. Purification was made by preparative TLC (hexanes–EtOAc, 95:5) to afford the aryl ether 5c (60.2 mg, 0.151 mmol, 80%). Ethyl 4-[3-Methoxy-5-(pentafluorosulfanyl)phenoxy]benzoate (5c) Rf = 0.30 (hexanes–EtOAc, 9:1). 1H NMR (400 MHz, CDCl3): δ = 8.06 (d, J = 8.8 Hz, 2 H), 7.09 (t, J = 2.1 Hz, 1 H), 7.06–7.01 (m, 3 H), 6.71 (t, J = 2.2 Hz, 1 H), 4.38 (q, J = 7.2 Hz, 2 H), 3.82 (s, 3 H), 1.40 (t, J = 7.1 Hz, 3 H). 13C NMR (101 MHz, CDCl3): δ = 166.0, 160.7, 160.3, 156.9, 155.4 (app m), 132.0, 126.3, 118.2, 109.9 (p, 3 J CF = 4.7 Hz), 108.3 (m, 2 C), 61.2, 56.1, 14.5. 19F NMR (282 MHz, CDCl3): δ = 83.7 (app m), 62.6 (d, 2 J FF = 149.8 Hz). IR (neat): 3407, 3104, 1714, 1600, 1588, 1504, 1467, 1448, 1274, 1222, 1162, 1147, 1099, 894, 835, 814, 760, 662, 597 cm–1. HRMS (EI): m/z calcd for [C16H15F5O4S]+: 398.0606; found: 398.0603. Zusatzmaterial Zusatzmaterial Supporting Information